The 24 kDa N-terminal sub-domain of the DNA gyrase B protein binds coumarin drugs - PubMed (original) (raw)
The 24 kDa N-terminal sub-domain of the DNA gyrase B protein binds coumarin drugs
E J Gilbert et al. Mol Microbiol. 1994 May.
Abstract
A number of lines of evidence suggest that the N-terminal sub-domain of the DNA gyrase B protein contains the binding site for the coumarin antibiotics. We have engineered a clone which encodes a 24 kDa protein which represents this domain. Bacteria which overproduce this protein show an elevated level of resistance to coumarins, suggestive of binding of the 24 kDa protein to the drugs in vivo. In vitro we find that the 24 kDa protein does not interact with the gyrase A or B proteins or with DNA, and fails to hydrolyse ATP or show significant binding to ATP, ADP or ADPNP. However, we show that the 24 kDa protein binds coumarin drugs as tightly as the intact B protein. A number of experiments suggest that the interaction of the coumarins with the protein is predominantly hydrophobic in nature.
Similar articles
- The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs.
Ali JA, Jackson AP, Howells AJ, Maxwell A. Ali JA, et al. Biochemistry. 1993 Mar 16;32(10):2717-24. doi: 10.1021/bi00061a033. Biochemistry. 1993. PMID: 8383523 - The interaction of coumarin antibiotics with fragments of DNA gyrase B protein.
Gormley NA, Orphanides G, Meyer A, Cullis PM, Maxwell A. Gormley NA, et al. Biochemistry. 1996 Apr 16;35(15):5083-92. doi: 10.1021/bi952888n. Biochemistry. 1996. PMID: 8664301 - Nucleotide binding to the 43-kilodalton N-terminal fragment of the DNA gyrase B protein.
Ali JA, Orphanides G, Maxwell A. Ali JA, et al. Biochemistry. 1995 Aug 1;34(30):9801-8. doi: 10.1021/bi00030a018. Biochemistry. 1995. PMID: 7626649 - The interaction between coumarin drugs and DNA gyrase.
Maxwell A. Maxwell A. Mol Microbiol. 1993 Aug;9(4):681-6. doi: 10.1111/j.1365-2958.1993.tb01728.x. Mol Microbiol. 1993. PMID: 8231802 Review. - The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action.
Heddle JG, Barnard FM, Wentzell LM, Maxwell A. Heddle JG, et al. Nucleosides Nucleotides Nucleic Acids. 2000 Aug;19(8):1249-64. doi: 10.1080/15257770008033048. Nucleosides Nucleotides Nucleic Acids. 2000. PMID: 11097055 Review.
Cited by
- The key DNA-binding residues in the C-terminal domain of Mycobacterium tuberculosis DNA gyrase A subunit (GyrA).
Huang YY, Deng JY, Gu J, Zhang ZP, Maxwell A, Bi LJ, Chen YY, Zhou YF, Yu ZN, Zhang XE. Huang YY, et al. Nucleic Acids Res. 2006;34(19):5650-9. doi: 10.1093/nar/gkl695. Epub 2006 Oct 11. Nucleic Acids Res. 2006. PMID: 17038336 Free PMC article. - Exploiting bacterial DNA gyrase as a drug target: current state and perspectives.
Collin F, Karkare S, Maxwell A. Collin F, et al. Appl Microbiol Biotechnol. 2011 Nov;92(3):479-97. doi: 10.1007/s00253-011-3557-z. Epub 2011 Sep 9. Appl Microbiol Biotechnol. 2011. PMID: 21904817 Free PMC article. Review. - Topoisomerases as anticancer targets.
Delgado JL, Hsieh CM, Chan NL, Hiasa H. Delgado JL, et al. Biochem J. 2018 Jan 23;475(2):373-398. doi: 10.1042/BCJ20160583. Biochem J. 2018. PMID: 29363591 Free PMC article. Review. - The ectodomain of the Toll-like receptor 4 prevents constitutive receptor activation.
Panter G, Jerala R. Panter G, et al. J Biol Chem. 2011 Jul 1;286(26):23334-44. doi: 10.1074/jbc.M110.205419. Epub 2011 May 4. J Biol Chem. 2011. PMID: 21543336 Free PMC article. - Oligomerization-primed coiled-coil domain interaction with Ubc13 confers processivity to TRAF6 ubiquitin ligase activity.
Hu L, Xu J, Xie X, Zhou Y, Tao P, Li H, Han X, Wang C, Liu J, Xu P, Neculai D, Xia Z. Hu L, et al. Nat Commun. 2017 Oct 9;8(1):814. doi: 10.1038/s41467-017-01290-0. Nat Commun. 2017. PMID: 28993672 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources